Why attend the 5th Nasal Formulation & Delivery Summit?
Here is what some of our expert speakers had to say…
Stuart Madden, Chief Scientific Officer – Neurelis:
Nose to brain delivery is an established pathway for the delivery of drugs directly to the brain but it is a complex drug development pathway with numerous clinical and regulatory challenges. This meeting will be exploring numerous aspects of these challenges to provide attendees with a better understanding of the current state of the art for nose-to-brain delivery.
Paul Radspinner, President & Chief Executive Officer – Flugen:
Intranasal delivery and mucosal immunity are gaining more attention every day as the vaccines and treatment communities are waking up to the power of this pathway.
Robert Rönn, Senior Vice President and Head of Research & Development - Orexo AB
The meeting provides an opportunity to learn from peers, exchange experiences, and identify ideas and collaborations that can benefit our R&D strategy and execution.
Sefi Rosenfeld, Director, Pre-Clinical & Early Clinical Development – Nasus Pharma:
I will be exposed to the recent developments in intranasal formulations and will be able to share challenges and optional solutions. This will be an opportunity to network with colleagues from the Nasal therapeutics industry.
Explore the Agenda
Hear the latest industry breakthroughs and gain exclusive insights during our packed agenda, interactive roundtables, and panel discussions.
Partner With Us
Position yourself alongside other leading solution providers to ensure your brand is at the heart of biopharma deals.
Join Biopharma Experts
Be part of the hottest conversations with like-minded attendees spanning all stages of drug development and make critical connections during our dedicated networking sessions.